GlucoMe is a digital health startup focused on diabetes management. The company offers a comprehensive digital solution that includes a Decision Support System analyzing relevant diabetes data and providing treatment recommendations. This platform enables remote care and monitoring, simplifying diabetes management for patients and medical professionals. Founded in 2013, GlucoMe received Seed Round investment in October 2013 from Dov Moran, supporting its vision of offering an autonomous diabetes healthcare platform. The company's innovative offerings include a wireless blood glucose monitor, a mobile app, a cloud-based diabetes monitoring software, and a Control Tower for data-driven prioritization and management. GlucoMe's smart and cost-effective approach has the potential to make a significant impact in the healthcare industry. For more information, visit www.glucome.com and follow the company on LinkedIn and Facebook.
GlucoMe
Empowering Digital Diabetes Care
General Information
Get notified when GlucoMe moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track GlucoMe
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health Care
About GlucoMe
Taxonomy: Digital Health, Diabetes Management, Remote Monitoring, Health IT, Telemedicine, mHealth, Disease Management, Telehealth, Type 1 Diabetes, Type 2 Diabetes, Blood Glucose Monitoring
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | •••••• | 1 | •••• •••• | 01 Oct 2013 |
GlucoMe Alternatives & Competitors
EMPOWERING PATIENTS - IMPROVING OUTCOMES
Empowering healthier lifestyles with innovative, culturally sensitive diabetes education and program...
FAQ About GlucoMe
Don't just browse. Track.
Signal Tracker monitors GlucoMe and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.